Wells Fargo Maintains Overweight on Accenture, Lowers Price Target to $248

Benzinga Newsdesk www.benzinga.com Negative 89.7%

Neg 89.7% Neu 0% Pos 0%

Wells Fargo analyst Jason Kupferberg maintains Accenture (NYSE:ACN) with a Overweight and lowers the price target from $275 to $248.